"Volvat i Fredrikstad finner du i Helsehuset på Kråkerøy rett overfor stadion. Her finner du et moderne medisinsk senter med egen sykehusenhet og mange medisinske spesialiteter."

During the past decade, Volvat Medisinske Senter conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Volvat Medisinske Senter" are "Dyslipidemia" (2 trials), "Hypercholesterolemia" (1 trials) and "Primary Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Volvat Medisinske Senter" in a lesser frequency.

Most popular intervention types in "Volvat Medisinske Senter" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (2 trials), "Atorvastatin" (1 trials) and "Simvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Volvat Medisinske Senter" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Volvat Medisinske Senter". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Volvat Medisinske Senter, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Volvat Medisinske Senter, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".